Interview with AmyriAD CEO Sharon L. Rogers
Oct 13, 2022•21 min•Season 1Ep. 107
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Sharon L. Rogers, PhD is leading the development of a new treatment for Alzheimer's. AmyriAD, where Sharon is CEO is in late stage trials for a drug that is designed to improve global function and cognition when used in combination with donepezil (Aricept).
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:
- Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
- Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
- YouTube https://www.youtube.com/@CareTalkPodcast
- CareTalk website https://www.caretalkpodcast.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.
Episodes through March 2025 were produced by Dafna Williams.
For the best experience, listen in Metacast app for iOS or Android